1-32595066-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001040441.3(ZBTB8A):c.836G>A(p.Arg279Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000471 in 1,613,412 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000051 ( 1 hom. )
Consequence
ZBTB8A
NM_001040441.3 missense
NM_001040441.3 missense
Scores
5
13
Clinical Significance
Conservation
PhyloP100: 3.99
Genes affected
ZBTB8A (HGNC:24172): (zinc finger and BTB domain containing 8A) Predicted to enable RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.077023864).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZBTB8A | NM_001040441.3 | c.836G>A | p.Arg279Gln | missense_variant | 4/5 | ENST00000373510.9 | NP_001035531.2 | |
ZBTB8A | NM_001291496.2 | c.836G>A | p.Arg279Gln | missense_variant | 4/5 | NP_001278425.1 | ||
ZBTB8A | NR_111980.2 | n.241G>A | non_coding_transcript_exon_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBTB8A | ENST00000373510.9 | c.836G>A | p.Arg279Gln | missense_variant | 4/5 | 1 | NM_001040441.3 | ENSP00000362609.3 | ||
ZBTB8A | ENST00000316459.4 | c.836G>A | p.Arg279Gln | missense_variant | 4/5 | 1 | ENSP00000317561.4 | |||
ENSG00000254553 | ENST00000480336.1 | n.*955G>A | non_coding_transcript_exon_variant | 9/10 | 2 | ENSP00000455300.1 | ||||
ENSG00000254553 | ENST00000480336.1 | n.*955G>A | 3_prime_UTR_variant | 9/10 | 2 | ENSP00000455300.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151994Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151994
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000957 AC: 24AN: 250670Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135464
GnomAD3 exomes
AF:
AC:
24
AN:
250670
Hom.:
AF XY:
AC XY:
13
AN XY:
135464
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461418Hom.: 1 Cov.: 30 AF XY: 0.0000701 AC XY: 51AN XY: 727026
GnomAD4 exome
AF:
AC:
75
AN:
1461418
Hom.:
Cov.:
30
AF XY:
AC XY:
51
AN XY:
727026
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151994Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74222
GnomAD4 genome
AF:
AC:
1
AN:
151994
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
13
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 08, 2024 | The c.836G>A (p.R279Q) alteration is located in exon 4 (coding exon 2) of the ZBTB8A gene. This alteration results from a G to A substitution at nucleotide position 836, causing the arginine (R) at amino acid position 279 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.063
.;B
Vest4
MutPred
Loss of catalytic residue at R279 (P = 0.0392);Loss of catalytic residue at R279 (P = 0.0392);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at